2016
DOI: 10.1159/000444089
|View full text |Cite
|
Sign up to set email alerts
|

Safety and Diagnostic Yield of Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Diseases: A Comparative Study versus Video-Assisted Thoracoscopic Lung Biopsy and a Systematic Review of the Literature

Abstract: Background: A diagnosis of interstitial lung diseases (ILDs) may include surgical lung biopsy (SLB), which is associated with significant morbidity and mortality and also appreciable costs. Transbronchial lung cryobiopsy (TBLC) is adopting an important role. Objectives: The aim of this study was to compare the diagnostic yield (DY) and safety of TBLC and SLB in a large cohort of patients and to perform a systematic review of the literature as well as a meta-analysis. Methods: We performed a retrospective analy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

24
393
11
10

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 315 publications
(438 citation statements)
references
References 40 publications
24
393
11
10
Order By: Relevance
“…Pajares and coworkers (65) compared TBCB with standard forceps biopsies in a randomized control trial and showed that there was no significant difference in the occurrence of pneumothorax or moderate bleeding between the two groups. Lastly, TBCB has also been shown to have a lower median time of hospitalization (2.6 vs. 6.1 days, P<0.0001), and has been shown to have a lower mortality due to adverse events (0.3% vs. 2.7%) in comparison with VATS biopsy (67).…”
Section: Bronchoscopic Cryobiopsiesmentioning
confidence: 96%
“…Pajares and coworkers (65) compared TBCB with standard forceps biopsies in a randomized control trial and showed that there was no significant difference in the occurrence of pneumothorax or moderate bleeding between the two groups. Lastly, TBCB has also been shown to have a lower median time of hospitalization (2.6 vs. 6.1 days, P<0.0001), and has been shown to have a lower mortality due to adverse events (0.3% vs. 2.7%) in comparison with VATS biopsy (67).…”
Section: Bronchoscopic Cryobiopsiesmentioning
confidence: 96%
“…Overall, a more cautious approach and a possibly lower mortality rate can be expected now that risk factors have been identified. In the future, it is conceivable that cryobiopsy may be associated with a lower risk of mortality than video-assisted thoracoscopic surgery [23], although published studies show a variable incidence of complications.…”
mentioning
confidence: 99%
“…Only two patients needed subsequent surgical biopsy. cryobiopsy vs video-assisted thoracoscopic (VATS) lung biopsy (82.8% vs 98.7%, p=0.013) [15]. There was a signifi cant decrease in number of hospital days with cryobiopsy when compared to VATS lung biopsy (2.6 d vs 6.1 d, p<0.0001).…”
Section: Reviewmentioning
confidence: 96%